Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tanabe Pharma Corporation
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Completion of the 24-week treatment period in MT-1303-E04 as per protocol
Able to provide written informed consent and to comply with the requirements of the protocol
For males and females of reproductive potential, two methods of contraception must be used throughout the study and for 12 weeks after cessation of study medication. At least one of the methods of contraception must be a barrier method.
You may not be if
Permanent discontinuation of study medication prior to the end of treatment (EOT) visit in MT-1303-E04
Newly diagnosed diabetes mellitus during MT-1303-E04
